Sign in

CIK 0001907108 · <br>Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
854012572
Phone
(212) 547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
  1. DEF 14A Proxy Proxy Statement
  2. 424B3 Offering Prospectus
  3. 424B3 Offering Prospectus
  4. 8-K Event Material agreement · Other events
  5. 8-K Event Executive or director change
  6. 424B3 Offering Prospectus
  7. 8-K Event Other events
  8. EFFECT Other Notice of Effectiveness
  9. 424B3 Offering Prospectus
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. UPLOAD Other SEC-generated Letter
  12. S-1 Offering Registration Statement
  13. 8-K Event Material agreement · Results of operations · Unregistered share sale · Regulation FD disclosure
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 10-K Report Annual Report
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G Stake Amended Statement of Ownership
  18. SC 13G Stake Amended Statement of Ownership
  19. SC 13G Stake Amended Statement of Ownership
  20. SC 13G Stake Amended Statement of Ownership

Page 15 of 19 · 362 filings